DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 114 filers reported holding DYNE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,572 | +1167.7% | 175,387 | +1502.7% | 0.00% | – |
| Q2 2023 | $124 | -96.3% | 10,943 | -96.2% | 0.00% | -100.0% |
| Q1 2023 | $3,357 | +641.1% | 291,310 | +645.5% | 0.00% | – |
| Q4 2022 | $453 | -99.9% | 39,078 | +1.0% | 0.00% | – |
| Q3 2022 | $493,000 | +96.4% | 38,708 | +5.9% | 0.00% | – |
| Q2 2022 | $251,000 | -28.5% | 36,560 | +0.3% | 0.00% | – |
| Q1 2022 | $351,000 | -17.4% | 36,458 | +2.0% | 0.00% | – |
| Q4 2021 | $425,000 | -28.0% | 35,758 | -1.7% | 0.00% | – |
| Q3 2021 | $590,000 | -94.2% | 36,358 | -92.5% | 0.00% | -100.0% |
| Q4 2020 | $10,184,000 | +2.6% | 484,952 | -1.3% | 0.00% | 0.0% |
| Q3 2020 | $9,923,000 | – | 491,471 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $28,535,000 | 16.60% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $47,731,000 | 16.31% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $86,132,000 | 10.89% |
| Logos Global Management LP | 2,734,392 | $26,360,000 | 3.42% |
| Deep Track Capital, LP | 3,500,000 | $33,740,000 | 2.16% |
| Octagon Capital Advisors LP | 525,284 | $5,064,000 | 1.10% |
| HighVista Strategies LLC | 168,691 | $1,626,000 | 1.03% |
| Monashee Investment Management LLC | 279,704 | $2,696,000 | 0.78% |
| COMMODORE CAPITAL LP | 305,125 | $2,941,000 | 0.66% |
| RA Capital Management | 2,805,045 | $27,041,000 | 0.59% |